Investigational Drug Information for Phosphoric acid
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the drug development status for Phosphoric acid?
Phosphoric acid is an investigational drug.
There have been 8 clinical trials for Phosphoric acid.
The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2011.
The most common disease conditions in clinical trials are Pancreatic Neoplasms, Tooth Abrasion, and Gingival Recession. The leading clinical trial sponsors are CrystalGenomics, Inc., CSPC-NBP Pharmaceutical Co., Ltd., and Jinling Hospital, China.
Summary for Phosphoric acid
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,090 |
| WIPO Patent Applications | 2 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2011-07-01) |
| Vendors | 51 |
Recent Clinical Trials for Phosphoric acid
| Title | Sponsor | Phase |
|---|---|---|
| EXtended Use of FOsfomycin for the Treatment of CYstitis in Primary Care | Saltro | Phase 3 |
| EXtended Use of FOsfomycin for the Treatment of CYstitis in Primary Care | ZonMw: The Netherlands Organisation for Health Research and Development | Phase 3 |
| EXtended Use of FOsfomycin for the Treatment of CYstitis in Primary Care | MJM Bonten | Phase 3 |
Clinical Trial Summary for Phosphoric acid
Top disease conditions for Phosphoric acid
Top clinical trial sponsors for Phosphoric acid
US Patents for Phosphoric acid
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
